{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T08:58:41Z","timestamp":1759481921429,"version":"3.41.2"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1023\/a:1015671627577","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T19:22:22Z","timestamp":1041103342000},"page":"721-728","source":"Crossref","is-referenced-by-count":20,"title":["Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees"],"prefix":"10.1007","volume":"17","author":[{"given":"V.","family":"Sypsa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hadjipaschali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hatzakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"7","key":"402316_CR1","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1182\/blood.V85.7.1681.bloodjournal8571681","volume":"85","author":"HJ Alter","year":"1995","unstructured":"Alter HJ. To C or not to C: These are the questions. Blood 1995; 85(7): 1681\u20131695.","journal-title":"Blood"},{"key":"402316_CR2","first-page":"425","volume":"49","author":"WHO.","year":"1999","unstructured":"WHO. Hepatitis C \u2013 global prevalence (update). Wkly Epidemiol Rec 1999; 49: 425\u2013427.","journal-title":"Wkly Epidemiol Rec"},{"key":"402316_CR3","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/0264-410X(95)93547-M","volume":"13","author":"M Kane","year":"1995","unstructured":"Kane M. Global programme for control of hepatitis B infection. Vaccine 1995; 13(Suppl. 1): S47\u2013S49.","journal-title":"Vaccine"},{"key":"402316_CR4","first-page":"1","volume":"47","author":"CDC.","year":"1998","unstructured":"CDC. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998; 47(RR-19): 1\u201339.","journal-title":"MMWR"},{"issue":"6","key":"402316_CR5","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/hep.1840200611","volume":"20","author":"S Bellentani","year":"1994","unstructured":"Bellentani S, Tiribelli C, Saccoccio G, et al. Prevalence of chronic liver disease in the general population of Northern Italy: The Dionysos study. Hepatology 1994; 20(6): 1442\u20131449.","journal-title":"Hepatology"},{"issue":"4","key":"402316_CR6","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/hep.510260431","volume":"26","author":"V Guadagnino","year":"1997","unstructured":"Guadagnino V, Stroffolini T, Rapicetta M, et al. Prevalence, prognostic\/risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in Southern Italy. Hepatology 1997; 26(4): 1006\u20131011.","journal-title":"Hepatology"},{"issue":"5","key":"402316_CR7","first-page":"979","volume":"24","author":"S Kaur","year":"1996","unstructured":"Kaur S, Rybicki L, Bacon BR, et al. Performance characteristics and results of a large-scale screening program for viral hepatitis and prognostic\/risk factors associated with exposure to viral hepatitis B and C: Results of the national hepatitis screening survey. Hepatology 1996; 24(5): 979\u2013986.","journal-title":"Hepatology"},{"issue":"6","key":"402316_CR8","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/hep.510250630","volume":"25","author":"F Dubois","year":"1997","unstructured":"Dubois F, Desenclos JC, Mariotte N, Goudeau A and the Collaborative Study Group. Hepatitis C in a French population-based survey, 1994: Seroprevalence, frequency of viremia, genotype distribution, and prognostic\/risk factors. Hepatology 1997; 25(6): 1490\u20131496.","journal-title":"Hepatology"},{"issue":"1","key":"402316_CR9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/00365549609027143","volume":"28","author":"A Garcia-Fulgueiras","year":"1996","unstructured":"Garcia-Fulgueiras A, Tormo MJ, Rodriguez T, Perez-Flores D, Chirlaque D, Navarro C. Prevalence of hepatitis B and C markers in the south-east of Spain: An unlinked community-based serosurvey of 2,203 adults. Scand JInfect Dis 1996; 28(1): 17\u201320.","journal-title":"Scand JInfect Dis"},{"issue":"5","key":"402316_CR10","first-page":"415","volume":"29","author":"T Stroffolini","year":"1997","unstructured":"Stroffolini T, Guadagnino V, Chionne P, et al. A population based survey of hepatitis B virus infection in a southern Italian town. Ital JGastroenterol Hepatol 1997; 29(5): 415\u2013418.","journal-title":"Ital JGastroenterol Hepatol"},{"issue":"5","key":"402316_CR11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2893.1998.00112.x","volume":"5","author":"F Monica","year":"1998","unstructured":"Monica F, Lirussi F, Nassuato G, Castelletto MR, Mottola A, Okolicsanyi L. Hepatitis C virus infection and related chronic liver disease in a resident elderly population: The Silea Study. JViral Hepat 1998; 5(5): 345\u2013351.","journal-title":"JViral Hepat"},{"issue":"6","key":"402316_CR12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF01726451","volume":"19","author":"R Dal-Re","year":"1991","unstructured":"Dal-Re R, Aguilar L, Coronel P. Current prevalence of hepatitis B, A and C in a healthy Spanish population. A seroepidemiological study. Infection 1991; 19(6): 409\u2013413.","journal-title":"Infection"},{"issue":"1064","key":"402316_CR13","first-page":"142","volume":"111","author":"T Blakely","year":"1998","unstructured":"Blakely T, Salmond C, Tobias M. Hepatitis B virus carrier prevalence in New Zealand: Population estimates using the 1987 police and customs personnel survey. N Z Med J 1998; 111(1064): 142\u2013144.","journal-title":"N Z Med J"},{"issue":"4","key":"402316_CR14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2188\/jea.6.198","volume":"6","author":"F Sasaki","year":"1996","unstructured":"Sasaki F, Tanaka J, Moriya T, et al. Very low incidence rates of community-acquired hepatitis C virus infection in company employees, long-term inpatients, and blood donors in Japan. J Epidemiol 1996; 6(4): 198\u2013203.","journal-title":"J Epidemiol"},{"issue":"2","key":"402316_CR15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1017\/S0950268801005362","volume":"126","author":"HC Chang","year":"2001","unstructured":"Chang HC, Yu MW, Lu CF, Chiu YH, Chen CJ. Prognostic\/risk factors associated with hepatitis C virus infection in Taiwanese government employees. Epidemiol Infect 2001; 126(2): 291\u2013299.","journal-title":"Epidemiol Infect"},{"issue":"12","key":"402316_CR16","first-page":"1178","volume":"71","author":"S Andenaes","year":"2000","unstructured":"Andenaes S, Lie A, Degre M. Prevalence of hepatitis A, B, C, and E antibody in flying airline personnel. Aviat Space Environ Med 2000; 71(12): 1178\u20131180.","journal-title":"Aviat Space Environ Med"},{"issue":"7042","key":"402316_CR17","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/bmj.312.7042.1347","volume":"312","author":"CA Seymour","year":"1996","unstructured":"Seymour CA. Screening asymptomatic people at high risk for hepatitis C. The case for. Br Med J 1996; 312(7042): 1347\u20131348.","journal-title":"The case for. Br Med J"},{"issue":"7042","key":"402316_CR18","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/bmj.312.7042.1349","volume":"312","author":"MC Allison","year":"1996","unstructured":"Allison MC, Mills PR. Screening asymptomatic people at high risk for hepatitis C. The case against. Br Med J 1996; 312(7042): 1349\u20131350.","journal-title":"Br Med J"},{"issue":"9286","key":"402316_CR19","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 2001; 358(9286): 958\u2013965.","journal-title":"Lancet"},{"issue":"4","key":"402316_CR20","first-page":"307A","volume":"32","author":"BG Feagan","year":"2000","unstructured":"Feagan BG, Trepo C, Lindsay KL, et al. The impact of pegylated interferon alfa-2b on health-related quality of life in chronic hepatitis C patients. Hepatology 2000; 32(4): 307A.","journal-title":"Hepatology"},{"issue":"9","key":"402316_CR21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.7326\/0003-4819-132-9-200005020-00007","volume":"132","author":"AH Malik","year":"2000","unstructured":"Malik AH, Lee WM. Chronic hepatitis B virus infection: treatment strategies for the next millennium. Ann Intern Med 2000; 132(9): 723\u2013731.","journal-title":"Ann Intern Med"},{"issue":"2","key":"402316_CR22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1360-0443.1998.9322438.x","volume":"93","author":"M Malliori","year":"1998","unstructured":"Malliori M, Sypsa V, Psichogiou M, et al. A survey of blood borne viruses and associated risk behaviours in Greek prisons. Addiction 1998; 93(2): 243\u2013251.","journal-title":"Addiction"},{"issue":"2","key":"402316_CR23","first-page":"143","volume":"3","author":"A Roumeliotou-Karayannis","year":"1987","unstructured":"Roumeliotou-Karayannis A, Tassopoulos N, Karpodini E, et al. Prevalence of HBV, HDV and HIV infections among intravenous drug addicts in Greece. Eur Jepidemiol 1987; 3(2): 143\u2013146.","journal-title":"Eur Jepidemiol"},{"issue":"11","key":"402316_CR24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1258\/0956462971919075","volume":"8","author":"A Tsakris","year":"1997","unstructured":"Tsakris A, Kyriakis KP, Chryssou S, Papoutsakis G. Infection by hepatitis B and C virus in female and transexual Greek prostitutes with serological evidence of active syphilis. Int JSTD AIDS 1997; 8(11): 697\u2013699.","journal-title":"Int JSTD AIDS"},{"issue":"3","key":"402316_CR25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00145420","volume":"12","author":"A Malamitsi-Puchner","year":"1996","unstructured":"Malamitsi-Puchner A, Papacharitonos S, Sotos D, et al. Prevalence study of di.erent hepatitis markers among pregnant Albanian refugees in Greece. Eur J Epidemiol 1996; 12(3): 297\u2013301.","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"402316_CR26","first-page":"553","volume":"7","author":"GN Dalekos","year":"1995","unstructured":"Dalekos GN, Zervou E, Karabini F, Tsianos EV. Prevalence of viral markers among refugees from Southern Albania: increased incidence of infection with hepatitis A, B and D viruses. Eur JGastroenterol Hepatol 1995; 7(6): 553\u2013558.","journal-title":"Eur JGastroenterol Hepatol"},{"issue":"1","key":"402316_CR27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2893.1997.00125.x","volume":"4","author":"C Lionis","year":"1997","unstructured":"Lionis C, Koulentaki M, Biziagos E, Kouroumalis E. Current prevalence of hepatitis A, B and C in a well de.ned area in rural Crete, Greece. JViral Hepat 1997; 4(1): 55\u201361.","journal-title":"JViral Hepat"},{"issue":"2","key":"402316_CR28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00141800","volume":"1","author":"G Papaevangelou","year":"1985","unstructured":"Papaevangelou G, Roumeliotou-Karayannis A, Tassopoulos N, et al. Evaluation of methods of pre-vaccination screening for markers of hepatitis B infection. Eur Jepidemiol 1985; 1(2): 100\u2013103.","journal-title":"Eur Jepidemiol"},{"key":"402316_CR29","first-page":"11","volume":"30","author":"A Yannitsiotis","year":"1997","unstructured":"Yannitsiotis A, Bossinakou I, Louizou C, Panayotopoulou A, Mandalaki T. Jaundice and hepatitis B surface antigen and antibody in Greek haemophiliacs. Scand JHaematol Suppl 1997; 30: 11\u201315.","journal-title":"Scand JHaematol Suppl"},{"issue":"4","key":"402316_CR30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0030-4220(86)90416-0","volume":"61","author":"B Panis","year":"1986","unstructured":"Panis B, Roumeliotou-Karayannis A, Papaevangelou G, Richardson SC, Mitsis F. Hepatitis B virus infection in dentists and dental students in Greece. Oral Surg Oral Med Oral Pathol 1986; 61(4): 343\u2013345.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"4","key":"402316_CR31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1023\/A:1007378608773","volume":"13","author":"C Lionis","year":"1997","unstructured":"Lionis C, Frangoulis E, Koulentakis M, Biziagos E, Kouroumalis E. Prevalence of hepatitis A, B and C markers in school children of a rural area of Crete, Greece. Eur Jepidemiology 1997; 13(4): 417\u2013420.","journal-title":"Eur Jepidemiology"},{"issue":"33","key":"402316_CR32","first-page":"782","volume":"47","author":"C Goritsas","year":"2000","unstructured":"Goritsas C, Plerou I, Agaliotis S, et al. HCV infection in the general population of a Greek island: Prevalence and risk factors. Hepatogastroenterology 2000; 47(33): 782\u2013785.","journal-title":"Hepatogastroenterology"},{"key":"402316_CR33","first-page":"33","volume":"48","author":"CDC.","year":"1999","unstructured":"CDC. Recommendations to prevent hepatitis B virus transmission-United States. MMWR 1999; 48: 33\u201334.","journal-title":"MMWR"},{"issue":"5","key":"402316_CR34","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/hep.510290528","volume":"29","author":"S Deuffic","year":"1999","unstructured":"Deuffic S, Buffat L, Poynard T, Valleron AJ. Modeling the hepatitis C virus epidemic in France. Hepatology 1999; 29(5): 1596\u20131601.","journal-title":"Hepatology"},{"issue":"10","key":"402316_CR35","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2105\/AJPH.90.10.1562","volume":"90","author":"JB Wong","year":"2000","unstructured":"Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United states. Am JPublic Health 2000; 90(10): 1562\u20131569.","journal-title":"Am JPublic Health"},{"issue":"7","key":"402316_CR36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1155\/2000\/642707","volume":"14","author":"S Zou","year":"2000","unstructured":"Zou S, Tepper M, El Saadany S. Prediction of hepatitis C burden in Canada. Can Jgastroenterol 2000; 14(7): 575\u2013580.","journal-title":"Can Jgastroenterol"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015671627577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1015671627577\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015671627577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T05:18:45Z","timestamp":1753852725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1015671627577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["402316"],"URL":"https:\/\/doi.org\/10.1023\/a:1015671627577","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"type":"print","value":"0393-2990"},{"type":"electronic","value":"1573-7284"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}